Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
27.45
+0.40 (1.48%)
At close: Apr 28, 2026, 4:00 PM EDT
27.99
+0.54 (1.97%)
After-hours: Apr 28, 2026, 5:51 PM EDT
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$689,702
Market Cap
428.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Invivyd | 122 |
| Neumora Therapeutics | 96 |
| Century Therapeutics | 78 |
| Assembly Biosciences | 73 |
| Armata Pharmaceuticals | 60 |
| Lexeo Therapeutics | 59 |
| PureTech Health | 56 |
NGNE News
- 12 hours ago - Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy - Business Wire
- 8 days ago - Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors - Business Wire
- 20 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates - Business Wire
- 5 weeks ago - Neurogene Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Neurogene to Participate in Stifel 2026 Virtual CNS Forum - Business Wire
- 7 weeks ago - Neurogene Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Neurogene Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts